V. Morrison

发表

Pragmatic study designs for older adults with cancer: Report from the U13 conference.

J. Buckner, K. Ballman, R. Nipp, 2016, Journal of geriatric oncology.

Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma.

Randy D Gascoyne, R. Gascoyne, R. Fisher, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Risk of Febrile Neutropenia among Patients with Intermediate-grade non-Hodgkin's Lymphoma Receiving CHOP Chemotherapy

G. Lyman, J. Crawford, V. Morrison, 2003, Leukemia & lymphoma.

The epidemiology and outcomes of invasive Candida infections among organ transplant recipients in the United States: results of the Transplant‐Associated Infection Surveillance Network (TRANSNET)

G. Lyon, B. Alexander, J. Baddley, 2016, Transplant infectious disease : an official journal of the Transplantation Society.

Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guideline.

G. Rosner, J. Griggs, G. Lyman, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis.

J. Perfect, V. Morrison, D. Stevens, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Common occurrence of monoclonal B‐cell lymphocytosis among members of high‐risk CLL families

G. Marti, J. Cerhan, N. Camp, 2010, British journal of haematology.

Varicella-zoster virus-specific immune responses to herpes zoster in elderly participants in a trial of a clinically effective zoster vaccine.

K. Schmader, M. Irwin, R. Arbeit, 2009, The Journal of infectious diseases.

The impact of actual body weight-based chemotherapy dosing and body size on adverse events and outcome in older patients with breast cancer: Results from Cancer and Leukemia Group B (CALGB) trial 49907 (Alliance A151436).

H. Cohen, A. Jatoi, J. Ligibel, 2017, Journal of geriatric oncology.

The role of body mass index in survival outcome for lymphoma patients: US intergroup experience.

R. Gascoyne, L. Gordon, R. Fisher, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Safety of Herpes Zoster Vaccine in the Shingles Prevention Study

K. Schmader, R. Arbeit, L. Davis, 2010, Annals of Internal Medicine.

Invasive Non-Aspergillus Mold Infections in Transplant Recipients, United States, 2001–2006

G. Papanicolaou, E. Anaissie, G. Lyon, 2011, Emerging infectious diseases.

Infections in the Immunocompromised Host

V. Morrison, Cristina A. Baker, Cristina A. Baker, 2018 .

International Society of Geriatric Oncology Chemotherapy Taskforce: evaluation of chemotherapy in older patients--an analysis of the medical literature.

H. Wildiers, M. Aapro, C. Steer, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Arti Hurria, M.D.: A tribute to her shining legacy in the Alliance for Clinical Trials in Oncology.

H. Cohen, J. Buckner, J. Mandelblatt, 2020, Journal of geriatric oncology.

Non-Hodgkin's lymphoma in the elderly. Part 1: Overview and treatment of follicular lymphoma.

V. Morrison, 2007, Oncology.

Immunosuppression associated with novel chemotherapy agents and monoclonal antibodies.

V. Morrison, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Factors associated with second‐line triplet therapy in routine care in relapsed/refractory multiple myeloma

P. Hari, V. Morrison, S. Noga, 2018, Journal of clinical pharmacy and therapeutics.

Comparative Sensitivity of Transthoracic and Transesophageal Echocardiography in Diagnosis of Infective Endocarditis Among Veterans With Staphylococcus aureus Bacteremia

M. Kuskowski, V. Morrison, G. Filice, 2017, Open forum infectious diseases.

How I treat chronic lymphocytic leukemia in older patients.

V. Morrison, Bradley Heraly, 2015, Journal of geriatric oncology.

Post-transplant lymphoproliferative disorders following solid-organ transplantation

V. Morrison, A. Blaes, 2010, Expert review of hematology.

Rituximab therapy is effective for posttransplant lymphoproliferative disorders after solid organ transplantation

D. Dunn, N. Bartlett, V. Morrison, 2005, Cancer.

Appropriate Systemic Therapy Dosing for Obese Adult Patients With Cancer: ASCO Guideline Update

G. Rosner, J. Griggs, G. Lyman, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Combination chemotherapy in the treatment of follicular low-grade lymphoma.

V. Morrison, B. Peterson, 1993, Leukemia & lymphoma.

Chemoimmunotherapy with fludarabine and rituximab produces extended overall survival and progression-free survival in chronic lymphocytic leukemia: long-term follow-up of CALGB study 9712.

J. Byrd, J. Gribben, R. Larson, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Non-Hodgkin's lymphoma in the elderly. Part 2: treatment of diffuse aggressive lymphomas.

V. Morrison, 2007, Oncology.

Patterns of chemotherapy administration in patients with intermediate-grade non-Hodgkin's lymphoma.

V. Morrison, V. Picozzi, W. Carter, 2001, Oncology.

Impact of age on outcomes after initial therapy with chemotherapy and different chemoimmunotherapy regimens in patients with chronic lymphocytic leukemia: results of sequential cancer and leukemia group B studies.

J. Byrd, R. Larson, F. Appelbaum, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The impact of initial fludarabine therapy on transformation to Richter syndrome or prolymphocytic leukemia in patients with chronic lymphocytic leukemia: analysis of an intergroup trial (CALGB 9011)

R. Larson, F. Appelbaum, A. Belch, 2013, Leukemia & lymphoma.

Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET).

E. Anaissie, G. Lyon, K. Wannemuehler, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Practice Guidelines for Diseases Caused by Aspergillus

D. Denning, V. Morrison, D. Stevens, 2000 .

Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial

J. Baddley, G. Rahav, V. Morrison, 2016, The Lancet.

Immunogenicity of Inactivated Varicella Zoster Vaccine in Autologous Hematopoietic Stem Cell Transplant Recipients and Patients With Solid or Hematologic Cancer

M. Boeckh, L. Camacho, V. Morrison, 2020, Open forum infectious diseases.

Long-term persistence of zoster vaccine efficacy.

K. Schmader, R. Betts, M. Levin, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Persistence of the efficacy of zoster vaccine in the shingles prevention study and the short-term persistence substudy.

K. Schmader, R. Betts, M. Levin, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Genome-wide Association Study Identifies Multiple Risk Loci for Chronic Lymphocytic Leukemia

Paolo Vineis, Theodore R Holford, Peter Kraft, 2013, Nature Genetics.

Herpes zoster complicating bortezomib therapy of relapsed/refractory indolent B-cell and mantle cell lymphoma: an analysis of two phase II trials

R. Neuwirth, D. Esseltine, S. de Vos, 2013, Leukemia & lymphoma.

Common variation at 6 p 21 . 31 ( BAK 1 ) influences the risk of chronic lymphocytic leukemia *

Eran Halperin, Nicola J. Camp, Neil E. Caporaso, 2012 .

Common variation at 6p21.31 (BAK1) influences the risk of chronic lymphocytic leukemia.

Eran Halperin, Celine M Vachon, Neil E Caporaso, 2012, Blood.

Practice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America.

D. Denning, V. Morrison, D. Stevens, 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Endemic fungal infections in solid organ and hematopoietic cell transplant recipients enrolled in the Transplant‐Associated Infection Surveillance Network (TRANSNET)

E. Anaissie, G. Lyon, B. Alexander, 2014, Transplant infectious disease : an official journal of the Transplantation Society.

Echinocandin antifungals: review and update

V. Morrison, 2006, Expert review of anti-infective therapy.

A model to predict chemotherapy-related severe or febrile neutropenia in cycle one among breast cancer and lymphoma patients.

V. Morrison, M. Fridman, D. Delgado, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Myeloid growth factors: To use or not to use, that is the question

V. Morrison, 2006, Leukemia & lymphoma.

Update on prophylaxis and therapy of infection in patients with chronic lymphocytic leukemia

V. Morrison, 2001, Expert review of anticancer therapy.

Infections in patients with leukemia and lymphoma.

V. Morrison, 2014, Cancer treatment and research.

Spectrum of Infections Therapy With Alkylating Agents

V. Morrison, P. Wadhwa, 2013 .

Infectious complications of chronic lymphocytic leukaemia: pathogenesis, spectrum of infection, preventive approaches.

V. Morrison, 2010, Best practice & research. Clinical haematology.

Infectious complications in patients with chronic lymphocytic leukemia: pathogenesis, spectrum of infection, and approaches to prophylaxis.

V. Morrison, 2009, Clinical lymphoma & myeloma.

Management of infectious complications in patients with chronic lymphocytic leukemia.

V. Morrison, 2007, Hematology. American Society of Hematology. Education Program.

Infectious complications of chronic lymphocytic leukemia.

V. Morrison, P. Wadhwa, 2006, Seminars in oncology.

Executive Summary: Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.

D. Denning, J. Wingard, V. Morrison, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Clinical manifestations of Kingella kingae infections: case report and review.

V. Morrison, K. Wagner, Vicki A. Morrison, 1989, Reviews of infectious diseases.

Modeling the durability of ZOSTAVAX® vaccine efficacy in people ≥60 years of age.

R. Betts, E. Dasbach, V. Morrison, 2015, Vaccine.

Diagnosis and outcome of 100 consecutive patients with extreme granulocytic leukocytosis.

V. Morrison, G. Filice, M. Reding, 1998, The American journal of medicine.

Nosocomial septicemia in the cancer patient: the influence of central venous access devices, neutropenia, and type of malignancy.

C. Bloomfield, V. Morrison, B. Peterson, 1990, Medical and pediatric oncology.

Cardiovascular and bacteremic manifestations of Campylobacter fetus infection: case report and review.

V. Morrison, J. Chia, C. Tuazon, 1990, Reviews of infectious diseases.

Safety of zoster vaccine in elderly adults following documented herpes zoster.

K. Schmader, R. Betts, W. Keitel, 2013, The Journal of infectious diseases.

Oncologists' Perspectives on Individualizing Dose Selection for Patients With Metastatic Cancer

Laura A. Levit, Laura A Levit, Caroline Schenkel, 2022, JCO oncology practice.

The Spectrum of Non-Candida Fungal Infections following Bone Marrow Transplantation

V. Morrison, D. Weisdorf, R. Haake, 1993, Medicine.

Infections in the Immunocompromised Host

V. Morrison, Cristina A. Baker, 2018 .

Use of prophylactic pegfilgrastim for chemotherapy-induced neutropenia in the US: A review of adherence to present guidelines for usage.

J. Crawford, V. Morrison, D. Dale, 2021, Cancer treatment and research communications.

An overview of the management of infection and febrile neutropenia in patients with cancer.

V. Morrison, 2005, Supportive cancer therapy.

Caspofungin: an overview

V. Morrison, 2005, Expert review of anti-infective therapy.

B-cell lymphoproliferative disorders in solid-organ transplant patients: detection of Epstein-Barr virus by in situ hybridization.

D. Dunn, S. Gruber, V. Morrison, 1992, Human pathology.

Treatment with Fludarabine and Rituximab Produces Extended Overall Survival (OS) and Progression-Free Survival (PFS) in Chronic Lymphocytic Leukemia (CLL) without Increased Risk of Second Malignancy: Long-Term Follow up of CALGB Study 9712.

J. Byrd, J. Gribben, R. Larson, 2009 .

Alemtuzumab Increases Serious Infections in Patients with Previously Untreated Chronic Lymphocytic Leukemia (CLL) Receiving Fludarabine-Based Therapy: A Comparative Analysis of 3 Cancer and Leukemia Group B Studies (CALGB 9011, 9712, 19901).

J. Byrd, R. Larson, K. Rai, 2007 .

Prognostic factors for therapeutic outcome of diffuse small non‐cleaved cell lymphoma in adults

C. Bloomfield, D. Arthur, V. Morrison, 1994, American journal of hematology.

Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America.

Raoul Herbrecht, Thomas J Walsh, Kieren A Marr, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.

D. Denning, J. Wingard, V. Morrison, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Alternaria: a sinonasal pathogen of immunocompromised hosts.

V. Morrison, D. Weisdorf, Daniel J. Weisdorf, 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Review of the pharmacology and clinical studies of micafungin

V. Morrison, A. Bormann, 2009, Drug design, development and therapy.

Non-Candida fungal infections after bone marrow transplantation: risk factors and outcome.

V. Morrison, D. Weisdorf, R. Haake, 1994, The American journal of medicine.

Corynebacterium JK: A new pathogen in ventriculostomy infections

S. Luikart, V. Morrison, Eric L. Weinshel, 1991, Journal of Neuro-Oncology.

Malassezia: is it a pulmonary pathogen in the stem cell transplant population?

V. Morrison, A. Blaes, W. Cavert, 2009, Transplant infectious disease : an official journal of the Transplantation Society.

1211A Phase 3, Randomized, Double-Blind, Non-Inferiority Trial to Evaluate Efficacy and Safety of Isavuconazole versus Voriconazole in Patients with Invasive Mold Disease (SECURE): Outcomes in Invasive Aspergillosis Patients

J. Baddley, V. Morrison, D. Kontoyiannis, 2014, Open Forum Infectious Diseases.

Invasive Aspergillosis of the Larynx: Case Report and Review of the Literature

V. Morrison, M. Gapany, B. E. Richardson, 1996, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database.

Thomas J Walsh, Randall Walker, Kieren A Marr, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Mucormycosis in the BMT population.

V. Morrison, P. Mcglave, 1993, Bone marrow transplantation.

Emerging fungal pathogens in patients with hematologic malignancies and marrow/stem-cell transplant recipients.

V. Morrison, B. Jahagirdar, 2002, Seminars in respiratory infections.

A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.

P. Peduzzi, K. Schmader, M. Irwin, 2005, The New England journal of medicine.

Variations of the ataxia telangiectasia mutated gene in patients with chronic lymphocytic leukemia lack substantial impact on progression-free survival and overall survival: a Cancer and Leukemia Group B study

J. Byrd, J. Gribben, R. Larson, 2012, Leukemia & lymphoma.

Posttransplant T-cell lymphoproliferative disorders--an aggressive, late complication of solid-organ transplantation.

J. Manivel, V. Morrison, R. Mcglennen, 1996, Blood.

Addition of rituximab to fludarabine may prolong progression-free survival and overall survival in patients with previously untreated chronic lymphocytic leukemia: an updated retrospective comparative analysis of CALGB 9712 and CALGB 9011.

J. Byrd, R. Larson, F. Appelbaum, 2005, Blood.

Management of chronic lymphocytic leukemia (CLL) in the elderly: a position paper from an international Society of Geriatric Oncology (SIOG) Task Force

T. Shanafelt, L. Ysebaert, V. Morrison, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Observational Study of the Prevalence of Febrile Neutropenia in Patients Who Received Filgrastim or Pegfilgrastim Associated With 3-4 Week Chemotherapy Regimens in Community Oncology Practices

V. Morrison, D. Hershman, B. Ding, 2007, Journal of managed care pharmacy : JMCP.

The impact of age on delivered dose intensity and hospitalizations for febrile neutropenia in patients with intermediate-grade non-Hodgkin's lymphoma receiving initial CHOP chemotherapy: a risk factor analysis.

V. Morrison, V. Picozzi, W. Carter, 2001, Clinical lymphoma.

Clinical characteristics of post-transplant lymphoproliferative disorders.

D. Dunn, J. Manivel, V. Morrison, 1994, The American journal of medicine.

Randomized phase 2 study of fludarabine with concurrent versus sequential treatment with rituximab in symptomatic, untreated patients with B-cell chronic lymphocytic leukemia: results from Cancer and Leukemia Group B 9712 (CALGB 9712).

J. Byrd, R. Larson, K. Rai, 2003, Blood.

Diffuse large B-cell lymphoma in the elderly: impact of prognosis, comorbidities, geriatric assessment, and supportive care on clinical practice. An International Society of Geriatric Oncology (SIOG) expert position paper.

M. Aapro, V. Morrison, R. Stauder, 2015, Journal of geriatric oncology.

Geriatric assessment in older adults with Non-Hodgkin lymphoma: A Young International Society of Geriatric Oncology (YSIOG) review paper.

V. Morrison, K. Loh, P. Torka, 2022, Journal of geriatric oncology.

Therapeutic approaches to non-Hodgkin’s lymphoma in the elderly patient

V. Morrison, M. Ninan, 2009, Expert review of hematology.

Evolution of R-CHOP therapy for older patients with diffuse large B-cell lymphoma

V. Morrison, 2008, Expert review of anticancer therapy.

Analysis of age, estimated creatinine clearance and pretreatment hematologic parameters as predictors of fludarabine toxicity in patients treated for chronic lymphocytic leukemia: a CALGB (9011) coordinated intergroup study

R. Larson, H. Hurwitz, K. Rai, 2002, Cancer Chemotherapy and Pharmacology.

Genome-wide association study identifies a novel susceptibility locus at 6p21.3 among familial CLL.

Celine M Vachon, Neil E Caporaso, Gerald E Marti, 2011, Blood.

The role of caspofungin and the echinocandins in the antifungal armamentarium.

V. Morrison, 2002, Current opinion in investigational drugs.

Lois Shepherd, John D Hines, R. Larson, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Rituximab-CHOP Versus CHOP with or without Maintenance Rituximab in Patients 60 Years of Age or Older with Diffuse Large B-Cell Lymphoma (DLBCL): An Update.

R. Gascoyne, R. Fisher, T. Habermann, 2004 .

Impact of therapy With chlorambucil, fludarabine, or fludarabine plus chlorambucil on infections in patients with chronic lymphocytic leukemia: Intergroup Study Cancer and Leukemia Group B 9011.

R. Larson, F. Appelbaum, K. Rai, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Treatment approaches for older and oldest patients with diffuse large B-cell lymphoma - Use of non-R-CHOP alternative therapies and impact of comorbidities on treatment choices and outcome: A Humedica database retrospective cohort analysis, 2007-2015.

V. Morrison, A. Galaznik, A. Raju, 2019, Journal of geriatric oncology.

Treatment Patterns and Survival Outcomes in Patients With Follicular Lymphoma: A 2007 to 2015 Humedica Database Study

V. Morrison, M. Eaddy, A. Galaznik, 2019, Clinical lymphoma, myeloma & leukemia.

Telephone monitoring of distress in patients aged 65 years or older with advanced stage cancer

Susan Bauer-Wu, J. Holland, E. Small, 2006, Cancer.

Frontline therapy with R-CHOP for diffuse large B-cell lymphoma: Where have we come (or not come)? A Perspective.

V. Morrison, 2020, Journal of geriatric oncology.

Comparison of conventional prognostic indices in patients older than 60 years with diffuse large B‐cell lymphoma treated with R‐CHOP in the US Intergroup Study (ECOG 4494, CALGB 9793): consideration of age greater than 70 years in an elderly prognostic index (E‐IPI)

R. Advani, R. Gascoyne, R. Fisher, 2010, British journal of haematology.

Long-Term Survival Analysis of the North American Intergroup Study C9011 Comparing Fludarabine (F) and Chlorambucil (C) in Previously Untreated Patients with Chronic Lymphocytic Leukemia (CLL).

R. Larson, F. Appelbaum, A. Belch, 2009 .

The impact of Agent Orange exposure on prognosis and management in patients with chronic lymphocytic leukemia: a National Veteran Affairs Tumor Registry Study

D. Gilbertson, V. Morrison, L. Baumann Kreuziger, 2018, Leukemia & lymphoma.

High-dose therapy and transplantation in non-Hodgkin's lymphoma.

V. Morrison, B. Peterson, 1999, Seminars in oncology.

The infectious complications of chronic lymphocytic leukemia.

V. Morrison, 1998, Seminars in Oncology.

Personalized risk prediction for event‐free survival at 24 months in patients with diffuse large B‐cell lymphoma

J. Cerhan, R. Gascoyne, C. Copie-Bergman, 2016, American journal of hematology.

Diffuse Large B-Cell Lymphomas in Older Adults

V. Morrison, 2020, Geriatric Oncology.

Approach to therapy of diffuse large B-cell lymphoma in the elderly: the International Society of Geriatric Oncology (SIOG) expert position commentary.

M. Aapro, V. Morrison, R. Stauder, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Treatment of mantle cell lymphoma in older adults.

V. Morrison, D. Pease, 2018, Journal of geriatric oncology.

Maintenance rituximab (MR) compared to observation (OBS) after R-CHOP or CHOP in older patients (pts) with diffuse large B-cell lymphoma (DLBCL): An Intergroup E4494/C9793 update

R. Gascoyne, R. Fisher, T. Habermann, 2007 .

Patterns of growth factor usage and febrile neutropenia among older patients with diffuse large B-cell non-Hodgkin lymphoma treated with CHOP or R-CHOP: the Intergroup experience (CALGB 9793; ECOG-SWOG 4494)

R. Fisher, B. Cheson, T. Habermann, 2017, Leukemia & lymphoma.

A medicare database analysis of practice patterns in patients with mantle cell lymphoma.

D. Gilbertson, V. Morrison, Yi Peng, 2021, Journal of geriatric oncology.

Evaluation of treatment patterns and survival among patients with diffuse large B-cell lymphoma in the USA.

V. Morrison, M. Eaddy, A. Galaznik, 2019, Future oncology.

Economic burden of patients with diffuse large B-cell and follicular lymphoma treated in the USA.

V. Morrison, M. Eaddy, A. Galaznik, 2018, Future oncology.

Practice patterns in older patients with diffuse large B-cell lymphoma: A medicare analysis, 2007-2015.

D. Gilbertson, V. Morrison, Yi Peng, 2020, Journal of geriatric oncology.

Postoperative toxic shock syndrome.

V. Morrison, E. Oldfield, 1983, Archives of surgery.

Therapy with bortezomib plus lenalidomide for relapsed/refractory mantle cell lymphoma: final results of a phase II trial (CALGB 50501)

A. LaCasce, B. Cheson, Sin-Ho Jung, 2015, Leukemia & lymphoma.

Impact of primary prophylaxis on febrile neutropenia within community practices in the US

V. Morrison, D. Hershman, J. Malin, 2009, Journal of medical economics.

The impact of age and comorbidities on practice patterns and outcomes in patients with relapsed/refractory multiple myeloma in the era of novel therapies.

P. Hari, V. Morrison, M. Blazer, 2017, Journal of geriatric oncology.

Safety and efficacy of inactivated varicella zoster virus vaccine in immunocompromised patients with malignancies: a two-arm, randomised, double-blind, phase 3 trial.

L. Camacho, V. Morrison, I. Chan, 2019, The Lancet. Infectious diseases.

Septic arthritis due to Bacillus.

V. Morrison, J. Chia, 1986, Southern medical journal (Birmingham, Ala. Print).

The impact of Agent Orange exposure on presentation and prognosis of patients with chronic lymphocytic leukemia

V. Morrison, L. Baumann Kreuziger, G. Tarchand, 2014, Leukemia & lymphoma.

Approach to therapy of diffuse large B-cell lymphoma in the elderly: the International Society of Geriatric Oncology (SIOG) expert position commentary.

M. Aapro, V. Morrison, R. Stauder, 2015 .

Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.

D. Denning, J. Wingard, V. Morrison, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

R-CHOP Versus (vs) CHOP Followed by Maintenance Rituximab (MR) Vs Observation In Older Diffuse Large B-Cell Lymphoma (DLBCL) Patients (pts): Long-Term Follow-up of Intergroup E4494/C9793

R. Fisher, B. Cheson, T. Habermann, 2010 .

Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the infectious diseases society of America

D. Denning, J. Wingard, V. Morrison, 2016 .

Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting

B. Alexander, J. Sobel, V. Morrison, 2007, European Journal of Clinical Microbiology & Infectious Diseases.

lymphocytic leukemia ) influences the risk of chronic BAK1

E. Halperin, J. Cerhan, N. Camp, 2012 .

Fas ligand expression in the bone marrow in myelodysplastic syndromes correlates with FAB subtype and anemia, and predicts survival

R. Kratzke, G. Niehans, V. Morrison, 1999, Leukemia.

Long-term Persistence of Zoster Vaccine Ef fi cacy

K. Schmader, R. Betts, M. Levin, 2015 .

Use of Comprehensive Geriatric Assessment in Oncology Patients to Guide Treatment Decisions and Predict Chemotherapy Toxicity.

V. Morrison, Elyse Watkins, Mark A. Klein, 2021, Federal practitioner : for the health care professionals of the VA, DoD, and PHS.

Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.

D. Denning, J. Wingard, V. Morrison, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Personalized risk prediction for event‐free survival at 24 months in patients with diffuse large B‐cell lymphoma

J. Cerhan, R. Gascoyne, C. Copie-Bergman, 2016, American journal of hematology.

Common variation at 6p21.31 (BAK1) influences the risk of chronic lymphocytic leukemia.

E. Halperin, J. Cerhan, N. Camp, 2012, Blood.

Mortality by a proxy performance status as defined by a claims-based measure for disability status in older patients with newly diagnosed multiple myeloma in the United States.

Jiannong Liu, Shuling Li, V. Morrison, 2019, Journal of geriatric oncology.

Monoclonal B-Cell Lymphocytosis Is Commonly Observed Among Unaffected Members of High Risk CLL Families.

G. Marti, J. Cerhan, N. Camp, 2009 .